Aikium
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Nearly half of the human proteome remains inaccessible for traditional drug discovery, largely due to intrinsically disordered regions and the limitations of current protein structure models, which are trained on just a fraction of available data.
AI / Machine LearningDrug Delivery